Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 127,72
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 166,75
Anzahl: 2 verfügbar
In den WarenkorbPaperback. Zustand: Brand New. reprint edition. 273 pages. 10.00x7.00x0.67 inches. In Stock.
Taschenbuch. Zustand: Neu. Recombinant Virus Vaccines | Methods and Protocols | Maureen C. Ferran (u. a.) | Taschenbuch | x | Englisch | 2018 | Humana | EAN 9781493983230 | Verantwortliche Person für die EU: Humana Press in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
Zustand: New. 2018. Paperback. . . . . . Books ship from the US and Ireland.
Sprache: Englisch
Verlag: Springer New York, Springer New York, 2018
ISBN 10: 1493983237 ISBN 13: 9781493983230
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This volume provides readers with methods and protocols for understanding the development of recombinant viruses and their use as vaccines platforms. Recombinant Virus Vaccines: Methods and Protocols details the use of recombinant vaccines that are employed to either produce immunogens in vitro or elicit antibody production in vivo. The chapters in this book are divided into four parts: Part I explores double-stranded DNA viruses; Part II discusses negative sense single-stranded RNA viruses; Part III talks about positive sense single-stranded RNA viruses; and Part IV describes bacteriophages. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls.Thorough and cutting-edge, Recombinant Virus Vaccines: Methods and Protocolsis a valuable resource for scientists and clinicians who are interested in learning about and adopting methods for use in basic and biomedical research directed toward generating and developing recombinant viral vaccines.